Literature DB >> 10696031

Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis.

M Rovaris1, M Filippi, L Minicucci, G Iannucci, G Santuccio, F Possa, G Comi.   

Abstract

BACKGROUND AND
PURPOSE: We assessed whether the extent of macro- and microscopic disease in the cortical and subcortical brain tissue, as revealed by MR and magnetization transfer (MT) imaging, correlates with cognitive dysfunction in patients with multiple sclerosis (MS).
METHODS: Dual-echo rapid acquisition with relaxation enhancement (RARE), fast fluid-attenuated inversion recovery (fast-FLAIR), T1-weighted, and MT MR images of the brain were obtained from 16 MS patients with cognitive impairment and from six without. Impaired and unimpaired patients were similar across demographic and other disease-related variables. Total and cortical/subcortical lesion loads were assessed using RARE, fast-FLAIR, and T1-weighted sequences. In each patient, cortical/subcortical disease was also assessed by means of MT ratio (MTR) histographic analysis.
RESULTS: All the impaired patients had multiple hyperintense lesions in the cortical/subcortical regions on both RARE and fast-FLAIR images; two unimpaired patients had such lesions on the RARE images and four had them on the fast-FLAIR images. Total and cortical/subcortical RARE/fast-FLAIR hyperintense and T1 hypointense lesion loads were significantly greater in the group of cognitively impaired patients. Patients with cognitive deficits also had significantly lower MTR histographic values for all the variables. A multivariate regression model showed that average cortical/subcortical brain MTR was the only factor that was significantly associated with cognitive impairment.
CONCLUSION: The extent and severity of MS disease in the cortical and subcortical regions significantly influence the cognitive functions of MS patients. MTR histographic findings suggest that subtle changes undetectable by conventional imaging are also important in determining MS cognitive decline.

Entities:  

Mesh:

Year:  2000        PMID: 10696031      PMCID: PMC7975362     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  35 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Authors:  D H Miller; F Barkhof; I Berry; L Kappos; G Scotti; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

3.  Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery.

Authors:  M Filippi; T Yousry; C Baratti; M A Horsfield; S Mammi; C Becker; R Voltz; S Spuler; A Campi; M F Reiser; G Comi
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

4.  Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden.

Authors:  M A van Buchem; J C McGowan; D L Kolson; M Polansky; R I Grossman
Journal:  Magn Reson Med       Date:  1996-10       Impact factor: 4.668

5.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

6.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

7.  Executive function in multiple sclerosis. The role of frontal lobe pathology.

Authors:  J Foong; L Rozewicz; G Quaghebeur; C A Davie; L D Kartsounis; A J Thompson; D H Miller; M A Ron
Journal:  Brain       Date:  1997-01       Impact factor: 13.501

8.  Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

Authors:  M Filippi; G Iannucci; C Tortorella; L Minicucci; M A Horsfield; B Colombo; M P Sormani; G Comi
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  Correlation of volumetric magnetization transfer imaging with clinical data in MS.

Authors:  M A van Buchem; R I Grossman; C Armstrong; M Polansky; Y Miki; F H Heyning; M P Boncoeur-Martel; L Wei; J K Udupa; M Grossman; D L Kolson; J C McGowan
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  49 in total

1.  Neuroradiological imaging and neuropsychological testing in multiple sclerosis.

Authors:  I G Ainyette; P Bowers; H Llingüin
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

2.  Age-related, regional, hemispheric, and medial-lateral differences in myelin integrity in vivo in the normal adult brain.

Authors:  Carol L Armstrong; Elfrides Traipe; Jill V Hunter; John C Haselgrove; George E Ledakis; Emily M Tallent; David Shera; Mark A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

3.  In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis.

Authors:  F Bagnato; J A Butman; S Gupta; M Calabrese; L Pezawas; J M Ohayon; F Tovar-Moll; M Riva; M M Cao; S L Talagala; H F McFarland
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

4.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

5.  Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.

Authors:  H Vrenken; S A R B Rombouts; P J W Pouwels; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

Review 6.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

Review 7.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

8.  3D MPRAGE improves classification of cortical lesions in multiple sclerosis.

Authors:  F Nelson; A Poonawalla; P Hou; J S Wolinsky; P A Narayana
Journal:  Mult Scler       Date:  2008-11       Impact factor: 6.312

9.  Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Authors:  Matilde Inglese; Sumita Adhya; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-02       Impact factor: 6.200

10.  Relevance of the skewness index in DTI exploration of multiple sclerosis.

Authors:  Eliane Graulières; Jean-Albert Lotterie; Emmanuelle Cassol; Angélique Gerdelat; Michel Clanet; Isabelle Berry
Journal:  MAGMA       Date:  2008-11-08       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.